Acorda Therapeutics Chief Scientific Officer Andrew R. Blight Recognized among PharmaVOICE’s 100 Most Inspiring People

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Chief Scientific Officer Andrew R. Blight, Ph.D., has been named one of PharmaVOICE’s 100 Most Inspiring People in the life sciences industry for 2011. The PharmaVOICE 100 is an annual recognition of healthcare industry professionals who impact the life sciences through their passion for the healthcare sectors they serve, and inspire and motivate others within their organizations as well as their community.
MORE ON THIS TOPIC